Alphatec Holdings, Inc. (NASDAQ:ATEC) Shares Sold by Aquatic Capital Management LLC

Aquatic Capital Management LLC reduced its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report) by 78.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 77,924 shares of the medical technology company's stock after selling 287,376 shares during the period. Aquatic Capital Management LLC owned about 0.05% of Alphatec worth $715,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in ATEC. R Squared Ltd purchased a new position in Alphatec in the fourth quarter valued at $29,000. Nisa Investment Advisors LLC increased its stake in shares of Alphatec by 973.3% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,669 shares of the medical technology company's stock worth $43,000 after buying an additional 4,234 shares during the period. Newton One Investments LLC acquired a new stake in Alphatec in the fourth quarter valued at approximately $50,000. AlphaQuest LLC acquired a new position in Alphatec during the 4th quarter worth approximately $80,000. Finally, Summit Investment Advisors Inc. raised its holdings in shares of Alphatec by 14.1% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,890 shares of the medical technology company's stock valued at $100,000 after purchasing an additional 1,342 shares in the last quarter. 66.35% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ATEC has been the topic of several recent analyst reports. Barclays increased their target price on Alphatec from $20.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, January 22nd. Needham & Company LLC reaffirmed a "buy" rating and issued a $16.00 price target on shares of Alphatec in a report on Friday, May 2nd. Piper Sandler reissued an "overweight" rating and set a $15.00 price objective (up previously from $13.00) on shares of Alphatec in a report on Friday, May 2nd. StockNews.com upgraded shares of Alphatec from a "sell" rating to a "hold" rating in a research report on Friday, February 28th. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $20.00 target price on shares of Alphatec in a research report on Monday, April 14th. Two research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $17.89.

Insider Buying and Selling

In other news, EVP David Sponsel sold 33,732 shares of Alphatec stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $10.83, for a total transaction of $365,317.56. Following the completion of the sale, the executive vice president now directly owns 668,977 shares in the company, valued at $7,245,020.91. The trade was a 4.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Scott Lish sold 12,000 shares of the firm's stock in a transaction on Monday, May 5th. The stock was sold at an average price of $12.12, for a total value of $145,440.00. Following the sale, the chief operating officer now owns 826,251 shares in the company, valued at $10,014,162.12. This trade represents a 1.43 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 154,398 shares of company stock worth $1,731,787. 22.80% of the stock is owned by corporate insiders.

Alphatec Price Performance

Shares of NASDAQ:ATEC traded up $0.11 during midday trading on Wednesday, hitting $12.28. 464,477 shares of the stock were exchanged, compared to its average volume of 2,074,316. Alphatec Holdings, Inc. has a twelve month low of $4.88 and a twelve month high of $13.63. The company has a current ratio of 2.32, a quick ratio of 1.15 and a debt-to-equity ratio of 30.21. The company has a 50 day moving average price of $10.48 and a 200-day moving average price of $9.98. The stock has a market cap of $1.79 billion, a P/E ratio of -9.57 and a beta of 1.06.

Alphatec (NASDAQ:ATEC - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.23). Alphatec had a negative net margin of 31.06% and a negative return on equity of 541.39%. The business had revenue of $169.18 million during the quarter, compared to analyst estimates of $167.57 million. During the same quarter in the prior year, the company earned ($0.34) earnings per share. The firm's revenue for the quarter was up 22.2% compared to the same quarter last year. On average, research analysts forecast that Alphatec Holdings, Inc. will post -1.08 earnings per share for the current year.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.